The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
A randomized, open-label, Phase II trial evaluating the clinical benefit of a maintenance treatment targeting tumor molecular alterations in patients with advanced solid tumors.
 
Maud Toulmonde
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer; PharmaMar
 
Christophe Le Tourneau
Honoraria - Novartis
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Antoine Italiano
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Christelle Seigne
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Isabelle Laure Ray-Coquard
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); PharmaMar (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Roche Pharma AG
 
Claire Cropet
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Aude Flechon
Honoraria - Bayer; GlaxoSmithKline; Novartis
Research Funding - Bayer; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - Bayer; Novartis
 
Françoise Desseigne
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Marie Alt
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Christelle De La Fouchardiere
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Jerome Fayette
Leadership - Glycotope GmbH
 
Edith Borcoman
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Pierre-Etienne Heudel
No Relationships to Disclose
 
Laure Jaouen
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Mathilde Bernardin
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
David Pérol
Honoraria - Roche Pharma AG
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Jean-Yves Blay
Honoraria - Bayer; GlaxoSmithKline; Novartis; PharmaMar; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Novartis; PharmaMar; PharmaMar; Roche
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst)